- News Home
6 March 2014 1:04 pm ,
Vol. 343 ,
Early in April, the first of a fleet of environmental monitoring satellites will lift off from Europe's spaceport in...
Since 2000, U.S. government health research agencies have spent almost $1 billion on an effort to churn out thousands...
Magdalena Koziol, a former postdoc at Yale University, was the victim of scientific sabotage. Now, she is suing the...
Antiretroviral drugs can protect people from becoming infected by HIV. But so-called pre-exposure prophylaxis, or PrEP...
Two studies show that eating a diet low in protein and high in carbohydrates is linked to a longer, healthier life, and...
Considered an icon of conservation science, researchers at World Wildlife Fund (WWF) headquarters in Washington, D.C.,...
The new atlas, which shows the distribution of important trace metals and other substances, is the first product of...
- 6 March 2014 1:04 pm , Vol. 343 , #6175
- About Us
Hat in Hand, Specter Proposes New Agency to Race for the Cure
27 April 2009 1:46 am
Senator Arlen Specter (R-PA) says giving the U.S. National Institutes of Health billions more dollars isn't enough to bolster biomedical research. On Saturday at a clinical research meeting in Chicago, he proposed a new independent agency to move bench discoveries to the bedside. And he wants your money to help him keep his seat.
Specter led a push to give NIH $10.4 billion in the recent stimulus package. He's now drafted a bill to be introduced this week that would authorize NIH to receive that funding as part of its base budget, bringing the total to $40 billion.
He explains his plan at a Web site, specterforthecure.com, that also urges visitors to contribute to his election campaign—he's facing a difficult primary battle to hold onto his seat in 2010. The bill would also create what he calls the Cures Acceleration Network, an independent federal agency, funded at $2 billion a year, that would attempt to bridge the so-called valley of death between discovering a potential drug and testing it in patients.
The agency's aim would be to "turn discoveries in biomedical research into better health for the American people," said Specter, a two-time cancer survivor. Biotech companies, universities, and patient groups could all apply for the grants, Specter said.
At least one prominent scientist thinks the network is a great idea. Former National Human Genome Research Institute Director Francis Collins, who was at the same meeting, told ScienceInsider that Specter's proposal is a "bold step" and that "the medical community should ... line up and try to figure out how to make it happen."